| P. Falciparum Infection Dynamics and Transmission to Inform Elimination (NCT04053907) | London School of Hygiene and Tropical Medicine | 2019-08-15 |
| Effectiveness of Malaria Camps as Part of the Odisha State Malaria Elimination Drive (NCT03963869) | NYU Langone Health | 2019-08-03 |
| Repeat Ivermectin Mass Drug Administrations for MALaria Control II (NCT03967054) | Brian Foy | 2019-07-13 |
| Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Burkina Faso (NCT04157894) | PATH | 2019-07-07 |
| Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar (NCT06392152) | Pyae Linn Aung | 2019-07-01 |
| VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules (NCT03970993) | University of Oxford | 2019-06-17 |
| Single Low-dose Primaquine Efficacy and Safety. (NCT03352843) | Tropical Pesticides Research Institute, Tanzania | 2019-06-11 |
| Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa... (NCT03952650) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-05-23 |
| Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali (NCT03917654) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-04-24 |
| Infections in Migrants in Sweden - the Importance of Malaria and Other Parasitic Infections (NCT05086887) | Region Stockholm | 2019-04-15 |
| Malaria Birth Cohort (MBC) in Agogo, Ghana (NCT04050566) | Bernhard Nocht Institute for Tropical Medicine | 2019-04-08 |
| Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ) (NCT04002687) | Medicines for Malaria Venture | 2019-04-04 |
| Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia (NCT03996967) | Boston University | 2019-02-11 |
| A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults (NCT03824236) | GlaxoSmithKline | 2019-02-05 |
| Efficacy of Three Novel Bi-treated Long Lasting Insecticidal Nets (NCT03554616) | London School of Hygiene and Tropical Medicine | 2019-02-01 |
| Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua (NCT06036030) | Syamsudin Abdillah,Ph.D, Pharm D | 2019-01-11 |
| Aggressive Antipyretics for Fever Reduction in CNS Malaria (NCT03399318) | University of Rochester | 2019-01-07 |
| Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model (NCT03707041) | Medicines for Malaria Venture | 2018-11-16 |
| Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies (NCT04265573) | Groupe de Recherche Action en Sante | 2018-11-10 |
| VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection (NCT03906474) | University of Oxford | 2018-11-06 |
| An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP (NCT03707353) | University of Oxford | 2018-10-30 |
| Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis (NCT03278808) | U.S. Army Medical Research and Development Command | 2018-09-17 |
| Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve Adults (NCT03341754) | U.S. Army Medical Research and Development Command | 2018-09-15 |
| Defining Skin Immunity of a Bite of Key Insect Vectors in Humans (NCT03641339) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-09-05 |
| Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine (NCT03599596) | University College Hospital, Ibadan | 2018-09-01 |
| Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen (NCT03934450) | University of Mississippi, Oxford | 2018-08-17 |
| Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination (NCT03576313) | London School of Hygiene and Tropical Medicine | 2018-08-11 |
| P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a) (NCT03705624) | London School of Hygiene and Tropical Medicine | 2018-08-06 |
| Malaria in Strasbourg University Hospital (NCT03594084) | University Hospital, Strasbourg, France | 2018-08-01 |
| Safety and Pharmacokinetics Study of DM1157 to Treat Malaria (NCT03490162) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-31 |
| Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea (NCT03590340) | Sanaria Inc. | 2018-07-30 |
| Dynamics of Subclinical Malaria: Preliminary Study (NCT03483571) | Duke University | 2018-07-26 |
| Evaluation of a Digital Microscope for Malaria (NCT03512678) | University of Oxford | 2018-06-25 |
| Community Access to Rectal Artesunate for Malaria (NCT03568344) | Swiss Tropical & Public Health Institute | 2018-06-15 |
| Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children (NCT03521973) | Sanaria Inc. | 2018-06-14 |
| Monitoring of Perfusion in Sepsis and Malaria (NCT03641534) | University of Oxford | 2018-06-04 |
| Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali (NCT03510481) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-14 |
| Liberia National Community Health Assistant (NCHA) Program and Under-five Mortality (NCT05123378) | Last Mile Health | 2018-05-01 |
| Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP (NCT03542149) | Medicines for Malaria Venture | 2018-04-23 |
| Evaluation of a New Malaria Control Strategy Amongst Gold Miners Working Illegally in French Guiana (Malakit) (NCT03695770) | Centre Hospitalier de Cayenne | 2018-04-16 |
| Transmission Dynamics of Residual and Re-emerging Malaria in the Amazon: Defining a Roadmap to Malaria Elimination (NCT03689036) | Oswaldo Cruz Foundation | 2018-04-02 |
| Susceptibility of Gambian Adults to PfSPZ-Challenge Infection in the Controlled Human Malaria Infection Model (NCT03496454) | London School of Hygiene and Tropical Medicine | 2018-03-29 |
| Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa (NCT03208179) | Liverpool School of Tropical Medicine | 2018-03-29 |
| In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III) (NCT04370977) | Centro de Investigacao em Saude de Manhica | 2018-03-21 |
| Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults (NCT03420053) | Sanaria Inc. | 2018-02-07 |
| Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, Mali (NCT03304704) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-01-28 |
| Preventing Mental Health Problems After Childhood Severe Malaria (NCT03432039) | Makerere University | 2018-01-09 |
| Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria Prevention (NCT02938975) | Ifakara Health Institute | 2017-11-01 |
| MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria (NCT02880241) | Medicines for Malaria Venture | 2017-10-20 |
| Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age (NCT03276962) | GlaxoSmithKline | 2017-09-28 |
| Prevalence Survey of Antimalarial Drug Resistance Markers (NCT03217851) | University of Oxford | 2017-09-18 |
| Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas (NCT03128515) | Indiana University | 2017-07-26 |
| A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2 (NCT03203421) | University of Oxford | 2017-07-03 |
| Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children (NCT04167566) | Noguchi Memorial Institute for Medical Research | 2017-07-01 |
| Dose Escalation PfSPZ-CVac (NCT03083847) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-05 |
| Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults (NCT03162614) | GlaxoSmithKline | 2017-05-24 |
| Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers (NCT03163121) | Sanaria Inc. | 2017-05-12 |
| Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. (NCT02699099) | GlaxoSmithKline | 2017-05-10 |
| Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1 (NCT02898779) | University of Mississippi, Oxford | 2017-05-01 |
| A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration (NCT03084289) | University of Oxford | 2017-03-28 |
| Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo (NCT02940756) | Ministry of Public Health, Democratic Republic of the Congo | 2017-03-15 |
| Absolute BA and OZ439 PK Effect of Different OZ439 Dose Volumes and Cobicistat Co-administration Study (NCT04069221) | Medicines for Malaria Venture | 2017-02-28 |
| Impact of Malaria on Pregnant Women in Ouelessebougou, Mali (NCT02974608) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-02-15 |
| Mobilization at the Level of Schools on the Behavioral Change in Favor of the Fight Against Malaria in Mbandjock (NCT04570241) | Cameroon Coalition Against Malaria (CCAM) | 2017-01-20 |
| Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi (NCT03009526) | Kamuzu University of Health Sciences | 2017-01-17 |
| Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique (NCT02910934) | PATH | 2017-01-10 |
| Proactive Community Case Management (Pro-CCM) in Rural Madagascar (NCT05223933) | Institut Pasteur de Madagascar | 2016-12-12 |
| Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge (NCT02639299) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-08 |
| Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis (NCT02858817) | University Hospital Tuebingen | 2016-11-28 |
| Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2) (NCT02932072) | University of Oxford | 2016-11-10 |
| RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission (NCT02878200) | London School of Hygiene and Tropical Medicine | 2016-11-04 |
| Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea. (NCT02859350) | Sanaria Inc. | 2016-11-01 |
| Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers (NCT02963324) | University Hospital, Basel, Switzerland | 2016-11-01 |
| Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali (NCT02942277) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-10-21 |
| A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate (NCT02927145) | University of Oxford | 2016-10-17 |
| Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) Method (NCT02996513) | Wageningen University | 2016-10-01 |
| Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania (NCT02909712) | London School of Hygiene and Tropical Medicine | 2016-09-01 |
| Prevention of Malaria in HIV-uninfected Pregnant Women and Infants (NCT02793622) | University of California, San Francisco | 2016-09-01 |
| A Trial on Supervised Primaquine Use in Ethiopia (NCT02793388) | Menzies School of Health Research | 2016-09-01 |
| Sequential Optimization of Dose and Schedule of PfSPZ Vaccine (NCT02704533) | Sanaria Inc. | 2016-08-29 |
| A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant (NCT02925403) | University of Oxford | 2016-08-26 |
| A FIH Study to Investigate the Safety, Tolerability and PK of P218 (NCT02885506) | Medicines for Malaria Venture | 2016-08-24 |
| Early Life Cohort in Papua Indonesia (ELIPI Study) (NCT02793336) | Menzies School of Health Research | 2016-08-03 |
| A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP (NCT02905019) | University of Oxford | 2016-08-01 |
| Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali (NCT03035305) | Alliance for International Medical Action | 2016-08-01 |
| Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya (NCT02687373) | Sanaria Inc. | 2016-07-21 |
| Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire (NCT03074435) | Institut de Recherche pour le Developpement | 2016-07-01 |
| Phase 2 Efficacy Study of Primaquine and Methylene Blue (NCT02831023) | University of California, San Francisco | 2016-07-01 |
| Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children (NCT02414399) | University of Washington | 2016-06-28 |
| Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya (NCT02294201) | University of Notre Dame | 2016-06-01 |
| Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1 (NCT02836002) | Radboud University Medical Center | 2016-06-01 |
| Malaria Genetic Surveillance in Cambodia (NCT03384472) | University of Oxford | 2016-06-01 |
| Leiden University Medical Center Mini Donor Bank (NCT02810613) | Leiden University Medical Center | 2016-05-31 |
| Post-discharge Malaria Chemoprevention(PMC) Study (NCT02671175) | Liverpool School of Tropical Medicine | 2016-05-20 |
| Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers (NCT02788864) | Oxford University Clinical Research Unit, Vietnam | 2016-05-20 |
| Child Follow-up Until 2 Years (NCT02800109) | University of Oxford | 2016-05-01 |
| Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA) (NCT02739763) | University of Oxford | 2016-05-01 |
| Cohort Event Monitoring in Sub Saharan Africa (NCT02817919) | African Collaborating Centre for Pharmacovigilance | 2016-05-01 |
| MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B (NCT02783833) | Medicines for Malaria Venture | 2016-05-01 |
| Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A (NCT02783820) | Medicines for Malaria Venture | 2016-05-01 |